Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future.
Africa
COVID-19
health policy
misinformation
prevalence
review
treatment
unintended consequences
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2020
2020
Historique:
received:
02
06
2020
accepted:
23
07
2020
entrez:
19
10
2020
pubmed:
20
10
2020
medline:
20
10
2020
Statut:
epublish
Résumé
The COVID-19 pandemic has already claimed considerable lives. There are major concerns in Africa due to existing high prevalence rates for both infectious and non-infectious diseases and limited resources in terms of personnel, beds and equipment. Alongside this, concerns that lockdown and other measures will have on prevention and management of other infectious diseases and non-communicable diseases (NCDs). NCDs are an increasing issue with rising morbidity and mortality rates. The World Health Organization (WHO) warns that a lack of nets and treatment could result in up to 18 million additional cases of malaria and up to 30,000 additional deaths in sub-Saharan Africa. Document current prevalence and mortality rates from COVID-19 alongside economic and other measures to reduce its spread and impact across Africa. In addition, suggested ways forward among all key stakeholder groups. Contextualise the findings from a wide range of publications including internet-based publications coupled with input from senior-level personnel. Prevalence and mortality rates are currently lower in Africa than among several Western countries and the USA. This could be due to a number of factors including early instigation of lockdown and border closures, the younger age of the population, lack of robust reporting systems and as yet unidentified genetic and other factors. Innovation is accelerating to address concerns with available equipment. There are ongoing steps to address the level of misinformation and its consequences including fines. There are also ongoing initiatives across Africa to start addressing the unintended consequences of COVID-19 activities including lockdown measures and their impact on NCDs including the likely rise in mental health disorders, exacerbated by increasing stigma associated with COVID-19. Strategies include extending prescription lengths, telemedicine and encouraging vaccination. However, these need to be accelerated to prevent increased morbidity and mortality. There are multiple activities across Africa to reduce the spread of COVID-19 and address misinformation, which can have catastrophic consequences, assisted by the WHO and others, which appear to be working in a number of countries. Research is ongoing to clarify the unintended consequences given ongoing concerns to guide future activities. Countries are learning from each other.
Sections du résumé
BACKGROUND
BACKGROUND
The COVID-19 pandemic has already claimed considerable lives. There are major concerns in Africa due to existing high prevalence rates for both infectious and non-infectious diseases and limited resources in terms of personnel, beds and equipment. Alongside this, concerns that lockdown and other measures will have on prevention and management of other infectious diseases and non-communicable diseases (NCDs). NCDs are an increasing issue with rising morbidity and mortality rates. The World Health Organization (WHO) warns that a lack of nets and treatment could result in up to 18 million additional cases of malaria and up to 30,000 additional deaths in sub-Saharan Africa.
OBJECTIVE
OBJECTIVE
Document current prevalence and mortality rates from COVID-19 alongside economic and other measures to reduce its spread and impact across Africa. In addition, suggested ways forward among all key stakeholder groups.
OUR APPROACH
UNASSIGNED
Contextualise the findings from a wide range of publications including internet-based publications coupled with input from senior-level personnel.
ONGOING ACTIVITIES
UNASSIGNED
Prevalence and mortality rates are currently lower in Africa than among several Western countries and the USA. This could be due to a number of factors including early instigation of lockdown and border closures, the younger age of the population, lack of robust reporting systems and as yet unidentified genetic and other factors. Innovation is accelerating to address concerns with available equipment. There are ongoing steps to address the level of misinformation and its consequences including fines. There are also ongoing initiatives across Africa to start addressing the unintended consequences of COVID-19 activities including lockdown measures and their impact on NCDs including the likely rise in mental health disorders, exacerbated by increasing stigma associated with COVID-19. Strategies include extending prescription lengths, telemedicine and encouraging vaccination. However, these need to be accelerated to prevent increased morbidity and mortality.
CONCLUSION
CONCLUSIONS
There are multiple activities across Africa to reduce the spread of COVID-19 and address misinformation, which can have catastrophic consequences, assisted by the WHO and others, which appear to be working in a number of countries. Research is ongoing to clarify the unintended consequences given ongoing concerns to guide future activities. Countries are learning from each other.
Identifiants
pubmed: 33071775
doi: 10.3389/fphar.2020.01205
pmc: PMC7533592
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1205Subventions
Organisme : Medical Research Council
ID : MC_PC_16090
Pays : United Kingdom
Informations de copyright
Copyright © 2020 Ogunleye, Basu, Mueller, Sneddon, Seaton, Yinka-Ogunleye, Wamboga, Miljković, Mwita, Rwegerera, Massele, Patrick, Niba, Nsaikila, Rashed, Hussein, Hegazy, Amu, Boahen-Boaten, Matsebula, Gwebu, Chirigo, Mkhabela, Dlamini, Sithole, Malaza, Dlamini, Afriyie, Asare, Amponsah, Sefah, Oluka, Guantai, Opanga, Sarele, Mafisa, Chikowe, Khuluza, Kibuule, Kalemeera, Mubita, Fadare, Sibomana, Ramokgopa, Whyte, Maimela, Hugo, Meyer, Schellack, Rampamba, Visser, Alfadl, Malik, Malande, Kalungia, Mwila, Zaranyika, Chaibva, Olaru, Masuka, Wale, Hwenda, Kamoga, Hill, Barbui, Bochenek, Kurdi, Campbell, Martin, Phuong, Thanh and Godman.
Références
Lancet. 2020 May 30;395(10238):1669
pubmed: 32473665
J Int AIDS Soc. 2020 May;23(5):e25503
pubmed: 32378345
Front Pharmacol. 2019 Jul 19;10:763
pubmed: 31379565
JAMA Cardiol. 2020 Jul 1;5(7):819-824
pubmed: 32219357
Expert Rev Clin Pharmacol. 2015 Jan;8(1):77-94
pubmed: 25487078
Curr Hypertens Rep. 2014 Jun;16(6):437
pubmed: 24764197
Arch Med Res. 2020 Jul;51(5):363-374
pubmed: 32409144
Lancet. 2020 May 30;395(10238):1689-1690
pubmed: 32422123
Pan Afr Med J. 2020 May 07;35(Suppl 2):26
pubmed: 33623551
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
BJPsych Open. 2020 Apr 06;6(3):e48
pubmed: 32250235
Lancet Psychiatry. 2020 Apr;7(4):e21
pubmed: 32199510
Milbank Q. 2005;83(4):691-729
pubmed: 16279964
AIDS Patient Care STDS. 2015 May;29(5):248-66
pubmed: 25825938
PLoS One. 2017 Dec 28;12(12):e0190147
pubmed: 29284064
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
QJM. 2020 May 1;113(5):311-312
pubmed: 32227218
J Clin Invest. 2020 Jun 1;130(6):2757-2765
pubmed: 32254064
J Infect. 2019 Jan;78(1):8-18
pubmed: 29981773
Int J Technol Assess Health Care. 2017 Jan;33(5):599-604
pubmed: 29103380
Chaos Solitons Fractals. 2020 Nov;140:110103
pubmed: 32834629
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):307-311
pubmed: 32191691
N Engl J Med. 2020 Oct 15;383(16):1522-1534
pubmed: 32558485
Autoimmun Rev. 2020 Jul;19(7):102568
pubmed: 32376398
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Health Policy Plan. 2019 Apr 1;34(3):178-187
pubmed: 30977804
Front Pharmacol. 2014 Jun 17;5:106
pubmed: 24987370
Sci Rep. 2019 Jan 31;9(1):1015
pubmed: 30705369
Lancet. 2020 May 30;395(10238):1695-1704
pubmed: 32401715
AIDS. 2014 Mar;28 Suppl 2:S187-204
pubmed: 24849479
Front Public Health. 2020 May 27;8:235
pubmed: 32574304
Lancet. 2020 May 30;395(10238):1687-1688
pubmed: 32539939
Int J Antimicrob Agents. 2020 May;55(5):105954
pubmed: 32234467
Schizophr Bull. 2020 Jul 8;46(4):752-757
pubmed: 32343342
BMC Health Serv Res. 2020 Mar 19;20(1):234
pubmed: 32192481
S Afr Med J. 2020 Apr 30;110(6):466-468
pubmed: 32880554
Lancet Rheumatol. 2020 May;2(5):e255-e256
pubmed: 32368737
J Am Coll Cardiol. 2020 Jul 7;76(1):122-124
pubmed: 32387623
Cardiovasc J Afr. 2015 Mar-Apr;26(2 Suppl 1):S6-10
pubmed: 25962950
BMC Infect Dis. 2015 Jan 17;15:20
pubmed: 25595711
Front Pharmacol. 2018 Jan 18;8:942
pubmed: 29403372
Int J Tuberc Lung Dis. 2020 Jun 1;24(6):643-645
pubmed: 32553005
Circulation. 2018 Nov 27;138(22):2449-2451
pubmed: 30571350
Am J Chin Med. 2020;48(4):763-777
pubmed: 32349517
J Infect. 2020 Aug;81(2):e16-e25
pubmed: 32335169
Lancet Glob Health. 2020 Oct;8(10):e1264-e1272
pubmed: 32687792
J Med Virol. 2020 Jul;92(7):776-785
pubmed: 32297988
Front Pharmacol. 2020 Mar 26;11:357
pubmed: 32273845
Res Social Adm Pharm. 2021 Jan;17(1):1819-1824
pubmed: 32249102
Acad Emerg Med. 2020 Jun;27(6):493-504
pubmed: 32359203
PLoS One. 2017 Dec 21;12(12):e0189621
pubmed: 29267306
Braz J Psychiatry. 2020 Aug;42(4):451-452
pubmed: 32578690
Nat Hum Behav. 2020 Jul;4(7):677-687
pubmed: 32581299
J Infect. 2020 Jul;81(1):e21-e23
pubmed: 32283143
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Cochrane Database Syst Rev. 2020 Apr 8;4:CD013574
pubmed: 32267544
Sci Total Environ. 2020 Jul 10;725:138277
pubmed: 32278175
Clin Infect Dis. 2021 May 4;72(9):e334-e342
pubmed: 32738143
Pan Afr Med J. 2020 May 13;35(Suppl 2):34
pubmed: 33623559
Lancet Glob Health. 2020 Jun;8(6):e754-e755
pubmed: 32278364
PLoS One. 2020 May 11;15(5):e0233147
pubmed: 32392262
Sci Rep. 2021 Mar 2;11(1):4956
pubmed: 33654164
Curr Med Res Opin. 2020 Feb;36(2):301-327
pubmed: 31794332
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Acta Pharm Sin B. 2020 Jul;10(7):1192-1204
pubmed: 32834949
Pharmacoecon Open. 2020 Jun;4(2):203-205
pubmed: 32277366
Lancet. 2020 May 30;395(10238):1670-1671
pubmed: 32401712
Infect Control Hosp Epidemiol. 2021 Mar;42(3):364-365
pubmed: 32408922
Int J Tuberc Lung Dis. 2020 May 1;24(5):541-542
pubmed: 32398210
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Emerg Infect Dis. 2016 Mar;22(3):433-41
pubmed: 26886846
N Engl J Med. 2020 Jul 16;383(3):e11
pubmed: 32302075
J Med Virol. 2020 Jul;92(7):814-818
pubmed: 32253759
Hosp Pract (1995). 2020 Mar 14;48(2):51-67
pubmed: 32196395
N Engl J Med. 2020 Sep 3;383(10):994
pubmed: 32649078
Biosci Trends. 2020 Mar 16;14(1):72-73
pubmed: 32074550
Nature. 2020 Apr 3;:
pubmed: 32242116
Br J Psychiatry. 2007 Mar;190:192-3
pubmed: 17329736
J Community Health. 2020 Dec;45(6):1116-1122
pubmed: 32405905
New Microbes New Infect. 2020 Apr 14;35:100679
pubmed: 32322401
Front Pharmacol. 2014 Jun 10;5:109
pubmed: 24959145
N Engl J Med. 2020 Aug 6;383(6):517-525
pubmed: 32492293
Mayo Clin Proc. 2006 Oct;81(10):1361-7
pubmed: 17036562
Lancet. 2020 May 16;395(10236):1569-1578
pubmed: 32423584
Cleve Clin J Med. 2020 Sep 2;:
pubmed: 32371558
Am J Trop Med Hyg. 2020 Jun;102(6):1184-1188
pubmed: 32323646
JAMA. 2020 Jun 16;323(23):2371-2372
pubmed: 32459289
BMC Public Health. 2019 Apr 3;19(1):372
pubmed: 30943975
Expert Opin Pharmacother. 2019 Dec;20(18):2237-2255
pubmed: 31762343
JAMA. 2020 Oct 6;324(13):1307-1316
pubmed: 32876695
Nat Rev Cardiol. 2017 May;14(5):273-293
pubmed: 28230175
Lancet Infect Dis. 2020 Oct;20(10):1122-1123
pubmed: 32325035
Front Med (Lausanne). 2020 Apr 09;7:140
pubmed: 32328496
Front Public Health. 2018 Dec 05;6:328
pubmed: 30568938
Res Social Adm Pharm. 2021 Jan;17(1):2023-2026
pubmed: 32307319
J Rural Health. 2021 Jan;37(1):153-155
pubmed: 32277726
Expert Rev Pharmacoecon Outcomes Res. 2019 Jun;19(3):251-261
pubmed: 30696372
Pan Afr Med J. 2020 May 07;35(Suppl 2):25
pubmed: 33623550
JAMA. 2020 Oct 6;324(13):1330-1341
pubmed: 32876694
Twin Res Hum Genet. 2020 Dec;23(6):316-321
pubmed: 33558003
Integr Med Res. 2020 Jun;9(2):100407
pubmed: 32289016
Bull World Health Organ. 2019 Jan 01;97(1):10-23
pubmed: 30618461
Expert Rev Pharmacoecon Outcomes Res. 2020 Feb;20(1):1-26
pubmed: 32237953
Appl Health Econ Health Policy. 2020 Jun;18(3):339-343
pubmed: 32377982
Lancet. 2020 Apr 11;395(10231):1180-1181
pubmed: 32278374
J Med Internet Res. 2020 Apr 2;22(4):e18790
pubmed: 32240094
Chin Med. 2020 Apr 15;15:34
pubmed: 32308732
EClinicalMedicine. 2020 Jun 03;23:100404
pubmed: 32632416
PLoS One. 2018 Mar 29;13(3):e0195086
pubmed: 29596495
Pan Afr Med J. 2020 Apr 16;35(Suppl 2):7
pubmed: 32528618
Global Health. 2016 Aug 24;12(1):50
pubmed: 27558556
Lancet HIV. 2020 May;7(5):e314-e316
pubmed: 32304642
Expert Rev Anti Infect Ther. 2016 Dec;14(12):1215-1223
pubmed: 27548801
Front Med (Lausanne). 2020 May 22;7:250
pubmed: 32574338
Patient. 2020 Jun;13(3):255
pubmed: 32301034
JAMA. 2020 Jun 23;323(24):2493-2502
pubmed: 32392282
Infection. 2020 Oct;48(5):681-686
pubmed: 32394344
Curr HIV/AIDS Rep. 2018 Jun;15(3):233-244
pubmed: 29752699
J Am Acad Dermatol. 2020 Jul;83(1):e35
pubmed: 32305444
Mil Med Res. 2020 May 5;7(1):22
pubmed: 32370766
PLoS One. 2019 Aug 9;14(8):e0221022
pubmed: 31398244
BMJ. 2020 May 11;369:m1872
pubmed: 32393463
Br J Pharmacol. 2020 Nov;177(21):4813-4824
pubmed: 32329520
Appl Health Econ Health Policy. 2020 Jun;18(3):325-328
pubmed: 32249362
N Engl J Med. 2020 Dec 17;383(25):2451-2460
pubmed: 32412710
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):382-386
pubmed: 32240123
Int J Infect Dis. 2020 Jul;96:311-314
pubmed: 32413608
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):395-403
pubmed: 32334395
Pan Afr Med J. 2020 May 05;35(Suppl 2):21
pubmed: 33623546
Int J Biol Sci. 2020 Mar 15;16(10):1732-1738
pubmed: 32226291
BioDrugs. 2018 Dec;32(6):585-606
pubmed: 30499082
Indian J Med Ethics. 2020 Apr-Jun;V(2):103-105
pubmed: 32393447
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):589-596
pubmed: 32417708
N Engl J Med. 2020 Jun 18;382(25):2461-2462
pubmed: 32379956
Int J Tuberc Lung Dis. 2020 Jul 1;24(7):732-734
pubmed: 32718410
Nat Hum Behav. 2020 May;4(5):436-437
pubmed: 32246105
Int J Biol Sci. 2020 Mar 15;16(10):1745-1752
pubmed: 32226294
Diabetes Ther. 2016 Jun;7(2):241-58
pubmed: 27048292
Lancet Infect Dis. 2020 Oct;20(10):1119-1120
pubmed: 32450054
BMJ. 2020 Mar 24;368:m1201
pubmed: 32209544
J Int AIDS Soc. 2020 Apr;23(4):e25489
pubmed: 32293807
Virusdisease. 2020 Jun;31(2):161-173
pubmed: 32656310
Lancet. 2020 May 22;:
pubmed: 32450107
J Res Pharm Pract. 2017 Apr-Jun;6(2):120-125
pubmed: 28616436
J Glob Health. 2020 Jun;10(1):010332
pubmed: 32395245
Obesity (Silver Spring). 2020 May;28(5):847
pubmed: 32237212
Patient. 2019 Aug;12(4):361-363
pubmed: 31165399
J Exp Med. 2020 May 4;217(5):
pubmed: 32289152
Front Pharmacol. 2016 Sep 28;7:305
pubmed: 27733828
Int J Chronic Dis. 2020 Jan 22;2020:2190395
pubmed: 32099838
Nat Rev Microbiol. 2019 Jan;17(1):3
pubmed: 30467331
Res Social Adm Pharm. 2021 Feb;17(2):480-482
pubmed: 32241695
Anesthesiology. 2020 Jun;132(6):1317-1332
pubmed: 32195705
Res Social Adm Pharm. 2021 Jan;17(1):2032-2035
pubmed: 32245691
Nature. 2020 Apr;580(7803):306
pubmed: 32231320
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Obesity (Silver Spring). 2020 Jun;28(6):1005
pubmed: 32237206
Lancet. 2020 Mar 14;395(10227):841-842
pubmed: 32113508
Crit Care. 2020 Mar 16;24(1):91
pubmed: 32178711
BMJ. 2020 Apr 23;369:m1637
pubmed: 32327414
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):579-582
pubmed: 32416527
Lancet Infect Dis. 2019 Dec;19(12):1272-1273
pubmed: 31588041
JAMA. 2020 Jun 9;323(22):2252-2253
pubmed: 32347911
N Engl J Med. 2020 Jun 18;382(25):2411-2418
pubmed: 32379955
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Lancet. 2020 May 30;395(10238):1735-1738
pubmed: 32386564
Lancet Glob Health. 2020 May;8(5):e639-e640
pubmed: 32199468
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Res Social Adm Pharm. 2021 Jan;17(1):1967-1977
pubmed: 32389631
N Engl J Med. 2020 Jun 11;382(24):e95
pubmed: 32469479
Lancet Respir Med. 2020 Jun;8(6):e46-e47
pubmed: 32353251
N Engl J Med. 2014 Jan 30;370(5):444-54
pubmed: 24476433
Pathogens. 2020 Apr 20;9(4):
pubmed: 32325980
Asian J Psychiatr. 2020 Aug;52:102066
pubmed: 32302935
JAC Antimicrob Resist. 2020 Feb 18;2(1):dlaa001
pubmed: 34222959
Lancet. 2020 May 2;395(10234):1421-1422
pubmed: 32330427
Lancet Respir Med. 2020 Jun;8(6):547-548
pubmed: 32401711
Patient. 2018 Aug;11(4):377-389
pubmed: 29322308
Lancet Glob Health. 2020 Jul;8(7):e881-e883
pubmed: 32530422
J Int AIDS Soc. 2020 May;23(5):e25504
pubmed: 32365283
Res Social Adm Pharm. 2021 Jan;17(1):1988-1989
pubmed: 32224133
Psychiatry Clin Neurosci. 2011 Oct;65(6):549-60
pubmed: 22003987
Psychiatry Clin Neurosci. 2010 Oct;64(5):584-6
pubmed: 20939157
Nat Rev Immunol. 2020 Jun;20(6):335-337
pubmed: 32393823
Ann Intern Med. 2020 Jul 7;173(1):79
pubmed: 32479106
Lancet Infect Dis. 2020 May;20(5):542
pubmed: 32243817
Pharmacoeconomics. 2017 Dec;35(12):1271-1285
pubmed: 28836222
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
BMJ. 2020 Apr 20;369:m1548
pubmed: 32312785
Front Pharmacol. 2020 Mar 20;11:108
pubmed: 32265688
Pharmacol Res. 2020 Jul;157:104872
pubmed: 32360583
Clin Transl Sci. 2020 Nov;13(6):1087-1095
pubmed: 32881340
JAMA. 2020 May 12;323(18):1824-1836
pubmed: 32282022
Brain Behav Immun. 2020 Jul;87:132-133
pubmed: 32387510
Res Social Adm Pharm. 2021 Jan;17(1):1964-1966
pubmed: 32317154
J Crit Care. 2020 Jun;57:279-283
pubmed: 32173110
Clin Drug Investig. 2020 Jul;40(7):591-601
pubmed: 32468425
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
Int J Environ Res Public Health. 2020 May 12;17(10):
pubmed: 32408528
Ann Pharmacother. 2003 Mar;37(3):384-7
pubmed: 12639168
Brain Behav Immun. 2020 Jul;87:40-48
pubmed: 32298802
Front Pharmacol. 2020 Feb 21;11:15
pubmed: 32153393
Brain Behav Immun. 2020 Jul;87:172-176
pubmed: 32405150
Lancet Glob Health. 2020 May;8(5):e631-e632
pubmed: 32246918
JAMA. 2020 Jun 9;323(22):2329-2330
pubmed: 32329799
J Eval Clin Pract. 2019 Aug;25(4):565-574
pubmed: 29901241
Health Aff (Millwood). 2020 Jul;39(7):1237-1246
pubmed: 32407171
Hum Resour Health. 2018 Jan 11;16(1):3
pubmed: 29325554
J Diabetes Sci Technol. 2020 Jul;14(4):813-821
pubmed: 32389027
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Pathog Glob Health. 2019 Jun;113(4):191-205
pubmed: 31215326
Lancet Public Health. 2020 Jun;5(6):e309
pubmed: 32401709
AIDS Res Hum Retroviruses. 2020 Jul;36(7):545-549
pubmed: 32414291
Tob Induc Dis. 2020 Mar 20;18:20
pubmed: 32206052
EMBO Mol Med. 2020 Jun 8;12(6):e12465
pubmed: 32333818
Lancet Psychiatry. 2020 Mar;7(3):228-229
pubmed: 32032543
BMJ. 2020 Apr 8;369:m1432
pubmed: 32269046
J Epidemiol Community Health. 2020 Nov;74(11):964-968
pubmed: 32535550
Res Social Adm Pharm. 2020 Apr;16(4):583-586
pubmed: 32081569
JAMA. 2020 May 26;323(20):2001-2002
pubmed: 32338730
Hum Resour Health. 2020 Feb 11;18(1):10
pubmed: 32046723
Int Psychogeriatr. 2020 Oct;32(10):1217-1220
pubmed: 32450943
J Res Pharm Pract. 2018 Apr-Jun;7(2):77-82
pubmed: 30050960
BMJ Open. 2020 Jun 9;10(6):e039978
pubmed: 32518212
JAMA. 2020 May 19;323(19):1899-1900
pubmed: 32297900
Infect Control Hosp Epidemiol. 2021 Mar;42(3):375-376
pubmed: 32408917
Lancet. 2020 May 30;395(10238):1678-1680
pubmed: 32401713
JAMA Pediatr. 2020 Sep 01;174(9):882-889
pubmed: 32320004
Antibiotics (Basel). 2019 Dec 20;9(1):
pubmed: 31861923
Eur Respir J. 2020 May 7;55(5):
pubmed: 32269088
BMJ. 2020 May 22;369:m1985
pubmed: 32444460
BMJ. 2020 Apr 8;369:m1439
pubmed: 32269023
Int J Mol Sci. 2020 Apr 10;21(7):
pubmed: 32290293
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
Lancet. 2020 Jun 13;395(10240):e102
pubmed: 32504543
Expert Rev Anti Infect Ther. 2019 Jul;17(7):535-546
pubmed: 31257952
PLoS One. 2015 Jan 24;10(1):e0116949
pubmed: 25617837
Glob Health Action. 2018;11(1):1527556
pubmed: 30326795
Front Pharmacol. 2014 Jan 10;4:177
pubmed: 24454289
JAMA. 2020 Apr 14;323(14):1341-1342
pubmed: 32125371
Pan Afr Med J. 2020 Apr 14;35(Suppl 2):3
pubmed: 32528614
Int J Environ Res Public Health. 2020 Apr 23;17(8):
pubmed: 32340349